SLC18A3 and schizophrenia: ALFF alterations in schizophrenia patients without AVHs compared to HCs were significantly associated with 5-HT1a: (P = 0.049, FDR corrected), dopamine D2 (P = 0.022, FDR corrected), GABAa (P = 0.047, FDR corrected), and VAChT: (P = 0.005, FDR corrected) (Figure 2B and Supplementary Table 2).